Primary Non-Hodgkins lymphoma of the parotid gland
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Otorhinolaryngology |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942011000500017 |
Resumo: | Primary malignant lymphomas in the salivary glands are relatively rare. Clinical presentation is not characteristic and the disease is often overlooked resulting in diagnosis and treatment delays. AIM: To stress the importance of the diagnostic process and combined management, we present a series of eight patients with malignant lymphoma of the parotid who were diagnosed only after surgery and managed with radiation and chemotherapy. METHODS: Retrospective series of patients with primary malignant lymphoma of the parotid gland managed with radiotherapy and diagnostic surgical partial resection. RESULTS: After treatment completion we achieved a loco-regional control rate of 87.5%. Toxicity was charted according to the Common Toxicity Criteria and it was seen in six patients (75%). Six patients are still alive without evidence of recurrent disease in their last follow-up. CONCLUSION: Our study confirms that primary early stage Non-Hodgkin Lymphoma of the parotid gland is a disease with an excellent prognosis and a good local control rate, with minimal morbidity. |
id |
ABORL-F-1_fc15d8c97588794c19be705e3336fed5 |
---|---|
oai_identifier_str |
oai:scielo:S1808-86942011000500017 |
network_acronym_str |
ABORL-F-1 |
network_name_str |
Brazilian Journal of Otorhinolaryngology |
repository_id_str |
|
spelling |
Primary Non-Hodgkins lymphoma of the parotid glandlymphomalymphomanon-hodgkinparotid neoplasmsradiotherapysalivary glandsPrimary malignant lymphomas in the salivary glands are relatively rare. Clinical presentation is not characteristic and the disease is often overlooked resulting in diagnosis and treatment delays. AIM: To stress the importance of the diagnostic process and combined management, we present a series of eight patients with malignant lymphoma of the parotid who were diagnosed only after surgery and managed with radiation and chemotherapy. METHODS: Retrospective series of patients with primary malignant lymphoma of the parotid gland managed with radiotherapy and diagnostic surgical partial resection. RESULTS: After treatment completion we achieved a loco-regional control rate of 87.5%. Toxicity was charted according to the Common Toxicity Criteria and it was seen in six patients (75%). Six patients are still alive without evidence of recurrent disease in their last follow-up. CONCLUSION: Our study confirms that primary early stage Non-Hodgkin Lymphoma of the parotid gland is a disease with an excellent prognosis and a good local control rate, with minimal morbidity.Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial.2011-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942011000500017Brazilian Journal of Otorhinolaryngology v.77 n.5 2011reponame:Brazilian Journal of Otorhinolaryngologyinstname:Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)instacron:ABORL-CCF10.1590/S1808-86942011000500017info:eu-repo/semantics/openAccessDispenza,FrancescoCicero,GiuseppeMortellaro,GianlucaMarchese,DonatellaKulamarva,GauthamDispenza,Carloeng2011-10-17T00:00:00Zoai:scielo:S1808-86942011000500017Revistahttp://www.bjorl.org.br/https://old.scielo.br/oai/scielo-oai.phprevista@aborlccf.org.br||revista@aborlccf.org.br1808-86861808-8686opendoar:2011-10-17T00:00Brazilian Journal of Otorhinolaryngology - Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)false |
dc.title.none.fl_str_mv |
Primary Non-Hodgkins lymphoma of the parotid gland |
title |
Primary Non-Hodgkins lymphoma of the parotid gland |
spellingShingle |
Primary Non-Hodgkins lymphoma of the parotid gland Dispenza,Francesco lymphoma lymphoma non-hodgkin parotid neoplasms radiotherapy salivary glands |
title_short |
Primary Non-Hodgkins lymphoma of the parotid gland |
title_full |
Primary Non-Hodgkins lymphoma of the parotid gland |
title_fullStr |
Primary Non-Hodgkins lymphoma of the parotid gland |
title_full_unstemmed |
Primary Non-Hodgkins lymphoma of the parotid gland |
title_sort |
Primary Non-Hodgkins lymphoma of the parotid gland |
author |
Dispenza,Francesco |
author_facet |
Dispenza,Francesco Cicero,Giuseppe Mortellaro,Gianluca Marchese,Donatella Kulamarva,Gautham Dispenza,Carlo |
author_role |
author |
author2 |
Cicero,Giuseppe Mortellaro,Gianluca Marchese,Donatella Kulamarva,Gautham Dispenza,Carlo |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Dispenza,Francesco Cicero,Giuseppe Mortellaro,Gianluca Marchese,Donatella Kulamarva,Gautham Dispenza,Carlo |
dc.subject.por.fl_str_mv |
lymphoma lymphoma non-hodgkin parotid neoplasms radiotherapy salivary glands |
topic |
lymphoma lymphoma non-hodgkin parotid neoplasms radiotherapy salivary glands |
description |
Primary malignant lymphomas in the salivary glands are relatively rare. Clinical presentation is not characteristic and the disease is often overlooked resulting in diagnosis and treatment delays. AIM: To stress the importance of the diagnostic process and combined management, we present a series of eight patients with malignant lymphoma of the parotid who were diagnosed only after surgery and managed with radiation and chemotherapy. METHODS: Retrospective series of patients with primary malignant lymphoma of the parotid gland managed with radiotherapy and diagnostic surgical partial resection. RESULTS: After treatment completion we achieved a loco-regional control rate of 87.5%. Toxicity was charted according to the Common Toxicity Criteria and it was seen in six patients (75%). Six patients are still alive without evidence of recurrent disease in their last follow-up. CONCLUSION: Our study confirms that primary early stage Non-Hodgkin Lymphoma of the parotid gland is a disease with an excellent prognosis and a good local control rate, with minimal morbidity. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942011000500017 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942011000500017 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S1808-86942011000500017 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. |
publisher.none.fl_str_mv |
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. |
dc.source.none.fl_str_mv |
Brazilian Journal of Otorhinolaryngology v.77 n.5 2011 reponame:Brazilian Journal of Otorhinolaryngology instname:Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF) instacron:ABORL-CCF |
instname_str |
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF) |
instacron_str |
ABORL-CCF |
institution |
ABORL-CCF |
reponame_str |
Brazilian Journal of Otorhinolaryngology |
collection |
Brazilian Journal of Otorhinolaryngology |
repository.name.fl_str_mv |
Brazilian Journal of Otorhinolaryngology - Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF) |
repository.mail.fl_str_mv |
revista@aborlccf.org.br||revista@aborlccf.org.br |
_version_ |
1754575989772386304 |